Array BioPharma announces proposed public offering of common stock
Array BioPharma announced it has commenced an underwritten public offering of $100 million of shares of its common stock. Array BioPharma intends to grant underwriters a 30-day option to purchase up to an additional $15 million of shares of its common stock. September 27, 2016